tiprankstipranks
Advertisement
Advertisement

CBLL Stock Latest News

Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
Company AnnouncementsCeribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
18d ago
CBLL
Ceribell receives 510(k) premarket notification for brain monitor headband
PremiumThe Fly
Ceribell receives 510(k) premarket notification for brain monitor headband
27d ago
CBLL
Ceribell Earnings Call Highlights Strong Growth, Rising Costs
PremiumCompany Announcements
Ceribell Earnings Call Highlights Strong Growth, Rising Costs
2M ago
CBLL
Ceribell price target lowered to $28 from $30 at Canaccord
PremiumThe Fly
Ceribell price target lowered to $28 from $30 at Canaccord
2M ago
CBLL
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating
PremiumRatings
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating
2M ago
CBLL
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating
PremiumRatingsCeribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating
2M ago
CBLL
Ceribell reports Q4 EPS (36c), consensus (41c)
Premium
The Fly
Ceribell reports Q4 EPS (36c), consensus (41c)
2M ago
CBLL
Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M
Premium
The Fly
Ceribell sees FY26 revenue $111M-$115M, consensus $112.67M
2M ago
CBLL
CBLL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CBLL Earnings this Week: How Will it Perform?
2M ago
CBLL
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook
PremiumRatings
Ceribell: Strong Clinical Integration and AI-Driven Differentiation Support Buy Rating and High-Growth Outlook
3M ago
CBLL
Ceribell: Expanding Neurology Platform, Growing TAM, and Attractive Valuation Support Buy Rating
PremiumRatings
Ceribell: Expanding Neurology Platform, Growing TAM, and Attractive Valuation Support Buy Rating
4M ago
CBLL
Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity
PremiumRatings
Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity
4M ago
CBLL
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool
PremiumCompany AnnouncementsCeribell Wins FDA Breakthrough Status for LVO Stroke Tool
4M ago
8K
CBLL
Ceribell receives FDA breakthrough device designation for LVO SD monitor
Premium
The Fly
Ceribell receives FDA breakthrough device designation for LVO SD monitor
4M ago
CBLL
Ceribell director resigns to pursue other professional ventures
Premium
Company Announcements
Ceribell director resigns to pursue other professional ventures
4M ago
8K
CBLL
Ceribell price target raised to $30 from $29 at Canaccord
PremiumThe Fly
Ceribell price target raised to $30 from $29 at Canaccord
5M ago
CBLL
Ceribell, Inc. Extends Sunnyvale Office Leases
PremiumCompany Announcements
Ceribell, Inc. Extends Sunnyvale Office Leases
5M ago
8K
CBLL
Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance
PremiumRatings
Buy Rating Affirmed for Ceribell, Inc. Due to Innovative Neonate Technology and FDA Clearance
5M ago
CBLL
Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating
PremiumRatings
Ceribell, Inc.’s Delirium Solution Gains Early FDA Clearance, Boosting Market Potential and Supporting Buy Rating
5M ago
CBLL
Ceribell’s FDA Clearance Boosts Market Prospects and Expands Multi-Indication Platform
PremiumRatingsCeribell’s FDA Clearance Boosts Market Prospects and Expands Multi-Indication Platform
5M ago
CBLL
Ceribell price target raised to $29 from $20 at TD Cowen
Premium
The Fly
Ceribell price target raised to $29 from $20 at TD Cowen
5M ago
CBLL
Ceribell, Inc. Gains FDA Clearance for Delirium Device
Premium
Company Announcements
Ceribell, Inc. Gains FDA Clearance for Delirium Device
5M ago
8K
CBLL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >